From October 1, 2023 to December 31, 2023, the company has repurchased 364,093 shares, representing 1.79% for CAD 0.15 million. With this, the company has completed the repurchase of 719,203 shares, representing 3.53% for CAD 0.39 million under the buyback announced on August 29, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.43 CAD | -.--% | -2.27% | -12.24% |
Mar. 13 | Crescita Therapeutics Reports Q4 Net Loss of $0.01 Per Share | MT |
Mar. 13 | Tranche Update on Crescita Therapeutics Inc.'s Equity Buyback Plan announced on August 29, 2023. | CI |
1st Jan change | Capi. | |
---|---|---|
-12.24% | 6.09M | |
+30.59% | 699B | |
+25.07% | 571B | |
-4.69% | 364B | |
+18.12% | 326B | |
+2.79% | 286B | |
+14.68% | 236B | |
+4.71% | 198B | |
-12.43% | 194B | |
-3.23% | 154B |
- Stock Market
- Equities
- CTX Stock
- News Crescita Therapeutics Inc.
- Tranche Update on Crescita Therapeutics Inc.'s Equity Buyback Plan announced on August 29, 2023.